Sponsored by Thermo Fisher Scientific
Figure 1: Viable cell volume (VCV) and viability data for HIP CHO in the HyPerforma 3-L Glass Bioreactor and 50-L DynaDrive Single-Use Bioreactor cell runs
At least one report estimates that by 2025, 35% of biologics will be manufactured using enhanced processes, particularly perfusion-based bioprocessing. Results of two innovations that support this need for enhanced processes are examined below.
The Thermo Scientific HyPerforma DynaDrive Single-Use Bioreactor (SUB), the latest advancement in SUB technology, offers better performance than other bioreactors and scalability up to 5,000 L. Gibco High-Intensity Perfusion CHO Medium is formulated to provide exceptional performance and ease of use, with capability of sustaining >1 g/L/day continuous productivity, >100 x 106/mL cell density, and 95% viability at one vessel volume per day (VVD).
Fill out the form below to read the complete technology review and learn more about HyPerforma DynaDrive and Gibco High-Intensity Perfusion CHO medium now.
You May Also Like
